The MedTech industry suffers from an "information fog" due to fragmented data, causing costly delays in market clearance. IXI MedTech cuts through this fog by turning scattered data into clear, actionable intelligence, helping companies make faster, smarter decisions.

Our unique approach combines WISPRO's 20 years of regulatory and industry wisdom with Mavus's data science and clinical expertise. This fusion of deep domain knowledge and powerful analytics allows us to uncover insights that others miss.

We use advanced analytics, including our pioneered RFM model for FDA data and NLP, to transform complex data into clear insights. Our platform offers both goal-oriented (Impact-Driven) and exploratory (Data-Driven) paths to help you make strategic decisions.

Our vision is to create a single intelligence engine for the entire MedTech lifecycle. We started with FDA data and will expand to include patents, clinical trials, and post-market data, offering a complete market view and predictive insights.

We are currently in an invitation-only Beta Program. We invite industry leaders to join us and help shape the future of MedTech decision-making.